Becton Dickinson & Co
Becton Dickinson & Co (BDX) Covered Calls
Becton Dickinson & Co trades in the Medical Instruments & Supplies industry with an IV Rank of 55.56%, average versus the past year. BDX's highest covered call setup is the $230.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 7.70% out of the money with 15 days to expiration, a 7.84% return until expiration, and a 190.86% theoretical annualized return. Across the setups shown, annualized returns run from 66.20% to 190.86% at strikes between $220.00 and $280.00, with 15 to 134 days to expiration, as of Nov 5, 2026.
Read more
Running BDX covered calls helps you generate income from Becton Dickinson & Co shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best BDX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If BDX stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling BDX covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given BDX covered call is worth writing.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems.
| 2026-11-20 | 15 | 230.00 | 7.70 | 0.30 | 0.95 | 1675.00 | 7.84 | 190.86 | -0.14 | +0.11 | 51 | 0.65 |
| 2026-12-18 | 43 | 250.00 | 17.07 | 0.05 | 2.65 | 3650.00 | 17.09 | 145.08 | -0.02 | +0.11 | 5 | 2.60 |
| 2027-01-15 | 71 | 260.00 | 21.75 | 0.05 | 3.60 | 4650.00 | 21.77 | 111.94 | -0.02 | +0.12 | 5 | 3.55 |
| 2026-12-18 | 43 | 240.00 | 12.39 | 0.50 | 1.50 | 2695.00 | 12.62 | 107.12 | -0.23 | +0.11 | 20 | 1.00 |
| 2026-11-20 | 15 | 220.00 | 3.02 | 1.80 | 3.10 | 825.00 | 3.86 | 94.01 | -0.84 | +0.32 | 402 | 1.30 |
| 2027-01-15 | 71 | 250.00 | 17.07 | 0.60 | 1.15 | 3705.00 | 17.35 | 89.19 | -0.28 | +0.09 | 10 | 0.55 |
| 2027-03-19 | 134 | 280.00 | 31.12 | 0.40 | 1.50 | 6685.00 | 31.30 | 85.27 | -0.19 | +0.07 | 6 | 1.10 |
| 2026-12-18 | 43 | 230.00 | 7.70 | 2.00 | 2.85 | 1845.00 | 8.64 | 73.34 | -0.94 | +0.23 | 15 | 0.85 |
| 2027-03-19 | 134 | 270.00 | 26.43 | 0.65 | 3.40 | 5710.00 | 26.74 | 72.83 | -0.30 | +0.12 | 5 | 2.75 |
| 2027-01-15 | 71 | 240.00 | 12.39 | 1.05 | 2.55 | 2750.00 | 12.88 | 66.20 | -0.49 | +0.16 | 25 | 1.50 |
As of Nov 5, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV Rank55.56% Moderate
- Market cap (M$)58,168
- 52 weeks high1.77%
- 52 weeks low67.33%
- Analyst recommendationBuy
2.21 - Target price$200.38
-8.76% below the current stock price - Dividend—
- Payout ratio71.53%
- Earnings date2026-11-05
- P/E64.41
- Future P/E14.99
- EPS (ttm)3.32
- EPS growth next 5 years6.79%
As of Nov 5, 2026